Search Results 601-610 of 18028 for monoclonal antibody

  1. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  2. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  3. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  4. S1406 A Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer - Mayo Clinic

    Irinotecan hydrochloride and vemurafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such ...

  5. Hematology - Clinical trials

    ... monoclonal antibody, and compare them with clinical outcomes. A Study to ... The purpose of this study is to evaluate the immune and hematopoietic compartments in ...

  6. Vinorelbine Tartrate and Cyclophosphamide in Combination with Bevacizumab or Temsirolimus in Treating Patients with Recurrent or Refractory Rhabdomyosarcoma - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. ... 3 half-lives (or 6 weeks) must have elapsed since previous monoclonal ...

  7. Otolaryngology (ENT)/Head and Neck Surgery - Clinical trials

    Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

  8. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody treatment can help high-risk ...

  9. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

    Monoclonal antibodies, such as daratumumab, may block cancer growth in different ways by targeting certain cells. Giving ixazomib citrate, lenalidomide ...

  10. Publications - Srilekha Sridhara, M.B.B.S., M.D. - Mayo Clinic

    De Novo Glomerulonephritis with Chronic Antibody Mediated Rejection in a ... Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk ...